Paetau I, Khachik F, Brown E D, Beecher G R, Kramer T R, Chittams J, Clevidence B A
US Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Carotenoids Research Unit, MD 20705, USA.
Am J Clin Nutr. 1998 Dec;68(6):1187-95. doi: 10.1093/ajcn/68.6.1187.
The bioavailability of lycopene from tomato juice and 2 dietary supplements, each containing 70-75 mg lycopene, was studied in 15 healthy volunteers in a randomized, crossover design. Subjects ingested lycopene-rich tomato juice, tomato oleoresin, lycopene beadlets, and a placebo for 4 wk each while consuming self-selected diets. Treatment periods were separated by 6-wk washout periods. Plasma lycopene concentrations, assessed at baseline and weekly throughout the treatment periods, were significantly higher during tomato juice, oleoresin, and lycopene beadlet ingestion than during placebo ingestion. Mean (+/-SEM) increases in plasma lycopene at week 4 of tomato juice, oleoresin, and lycopene beadlet ingestion were not significantly different: 0.24 +/- 0.07, 0.23 +/- 0.05, and 0.24 +/- 0.06 micromol/L, respectively. Plasma concentrations of phytofluene and phytoene, which were present in small amounts in tomato juice, oleoresin, and lycopene beadlets, increased significantly with ingestion of these 3 products. Beta-carotene, zeta-carotene, and 2,6-cyclolycopene-1,5-diol (a metabolite of lycopene)--also present in tomato juice and supplements--were significantly increased with consumption of the tomato juice and lycopene beadlets, but not with oleoresin consumption. A marked increase in plasma concentrations of an unknown compound was observed; it was detected in trace amounts in tomato juice, oleoresin, and lycopene beadlets, and had a maximum absorbance at 448 nm and a molecular weight of 556. Concentrations of plasma lycopene and other carotenoids with potential for enhancing human health can be increased by ingestion of realistic amounts of tomato juice. Lycopene appears to be equally bioavailable from tomato juice and the supplements used in this study.
在一项随机交叉设计中,对15名健康志愿者研究了番茄汁和两种膳食补充剂(每种含70 - 75毫克番茄红素)中番茄红素的生物利用度。受试者在食用自选饮食的同时,分别摄入富含番茄红素的番茄汁、番茄油树脂、番茄红素微囊和安慰剂,各为期4周。治疗期之间间隔6周的洗脱期。在整个治疗期间,于基线及每周评估血浆番茄红素浓度,结果发现,摄入番茄汁、油树脂和番茄红素微囊期间的血浆番茄红素浓度显著高于摄入安慰剂期间。在摄入番茄汁、油树脂和番茄红素微囊第4周时,血浆番茄红素的平均(±标准误)增加值无显著差异,分别为0.24±0.07、0.23±0.05和0.24±0.06微摩尔/升。番茄汁、油树脂和番茄红素微囊中含量少量的八氢番茄红素和六氢番茄红素的血浆浓度,随着这三种产品的摄入而显著增加。番茄汁和补充剂中也含有的β-胡萝卜素、ζ-胡萝卜素和2,6-环化番茄红素-1,5-二醇(番茄红素的一种代谢物),随着番茄汁和番茄红素微囊的摄入而显著增加,但随着油树脂的摄入未显著增加。观察到一种未知化合物的血浆浓度显著升高;它在番茄汁、油树脂和番茄红素微囊中以痕量被检测到,在448纳米处有最大吸光度,分子量为556。摄入实际量的番茄汁可提高血浆番茄红素及其他具有增强人类健康潜力的类胡萝卜素的浓度。番茄汁中的番茄红素与本研究中使用的补充剂的生物利用度似乎相当。